Article: Oramed's Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England.(Conference news)

Article: Oral Insulin Studies Show Positive Safety And ...
Biotech Week;  July 25, 2001 ;     700+ words ... ... Phase II studies of its fast-acting oral insulin product for the treatment of diabetes ... Pennsylvania. The Nobex drug is the first oral insulin product to demonstrate clinical efficacy ... suggest the significant potential of oral insulin in managing mealtime blood sugar in ...

Article: Oral insulin data from two clinical studies ...
Biotech Week;  July 9, 2003 ;     700+ words ... ... from two clinical studies evaluating an oral insulin prototype, both of which were presented ... activity. In the first study, the oral insulin showed a very fast onset of action and ... These results support the prospect of an oral insulin product for use in both the early and ...

Article: Promising Emisphere(TM) Oral Insulin Data from Two ...
PR Newswire;  June 16, 2003 ;     700+ words ... ... from two clinical studies evaluating an oral insulin prototype, both of which were presented ... activity. In the first study, the oral insulin showed a very fast onset of action and ... These results support the prospect of an oral insulin product for use in both the early and ...

Article: Emisphere Reports Additional Clinical Data From Phase 2 ...
PR Newswire;  November 8, 2006 ;     700+ words ... ... Patients Across Three Dose Groups of Oral Insulin with Stable Hemoglobin A1c (HbA1c ... Decrease in HbA1c * Highest Dose of Oral Insulin Shown To Be Statistically Significant ... its 90-day, Phase 2 study of its oral insulin product utilizing the Company's eligen ...

Article: Nobex Corporation Presents Positive Data From Phase II Studies Of ...
PR Newswire;  June 25, 2001 ;     700+ words ...- Nobex Oral Insulin Shows Positive Safety and Efficacy ... Phase II studies of its fast-acting oral insulin product for the treatment of diabetes ... week. The Nobex drug is the first oral insulin product to demonstrate clinical effects ...

Article: Generex Biotechnology Reports Promising Data From Studies ...
PR Newswire;  June 28, 2001 ;     700+ words ... ... Oralin(TM), Generex' proprietary oral insulin formulation, may be used safely and ... study entitled "Long-Term Efficacy of Oral Insulin and Pioglitazone Combination Therapy ... weeks or more) efficacy of low doses of oral insulin in combination with pioglitazone against ...

Article: Emisphere Initiates U.S. Clinical Studies for an Oral ...
PR Newswire;  May 8, 2003 ;     700+ words ... ... is initiating clinical testing of an oral insulin formulation in type 2 diabetic patients ... insulin in a capsule. This is the first oral insulin clinical study in the United States ... and pharmacokinetics of Emisphere's oral insulin formulation with an EMISPHERE(R ...